CoformerAI is a startup based in the Netherlands, 1 tracked investor.
CoformerAI is a company founded in 2025 headquartered in the Netherlands. Brouky records 1 investor associated with the company.
CoformerAI accelerates drug development by using AI to pair APIs with coformers, overcoming solubility and bioavailability barriers. The platform employs proprietary molecular mechanism models and robotics to validate solubility gains, enabling partners to advance candidates into small-scale human trials within 12 months.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.